Literature DB >> 21701488

MicroRNA signatures characterize multiple myeloma patients.

S L Corthals, S M Sun, R Kuiper, Y de Knegt, A Broyl, B van der Holt, H B Beverloo, J K Peeters, L el Jarari, H M Lokhorst, S Zweegman, M Jongen-Lavrencic, P Sonneveld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21701488     DOI： 10.1038/leu.2011.147

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  29 in total

Review 1.  Gene Expression Profiles in Myeloma: Ready for the Real World?

Authors:  Raphael Szalat; Herve Avet-Loiseau; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2016-11-15       Impact factor: 12.531

2.  miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor.

Authors:  Xianjuan Shen; Yuehua Guo; Jiajia Yu; Jing Qi; Wei Shi; Xinhua Wu; Hongbing Ni; Shaoqing Ju
Journal:  Clin Exp Med       Date:  2015-05-14       Impact factor: 3.984

3.  Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.

Authors:  Michael W Gordon; Fang Yan; Xiaoming Zhong; Pranab Behari Mazumder; Zijun Y Xu-Monette; Dehui Zou; Ken H Young; Kenneth S Ramos; Yong Li
Journal:  Mol Carcinog       Date:  2014-05-06       Impact factor: 4.784

4.  The role of miR-200a in mammalian epithelial cell transformation.

Authors:  Lindsey E Becker; Apana Agha L Takwi; Zhongxin Lu; Yong Li
Journal:  Carcinogenesis       Date:  2014-09-19       Impact factor: 4.944

Review 5.  MicroRNA theragnostics for the clinical management of multiple myeloma.

Authors:  N Ahmad; S Haider; S Jagannathan; E Anaissie; J J Driscoll
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

6.  Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.

Authors:  Xianjuan Shen; Yuehua Guo; Jing Qi; Wei Shi; Xinhua Wu; Hongbing Ni; Shaoqing Ju
Journal:  Pathol Oncol Res       Date:  2015-12-21       Impact factor: 3.201

7.  Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.

Authors:  Emanuela Leone; Eugenio Morelli; Maria T Di Martino; Nicola Amodio; Umberto Foresta; Annamaria Gullà; Marco Rossi; Antonino Neri; Antonio Giordano; Nikhil C Munshi; Kenneth C Anderson; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

8.  Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.

Authors:  Xiaoyan Qu; Min Zhao; Shuang Wu; Wenjun Yu; Jiaren Xu; Ji Xu; Jianyong Li; Lijuan Chen
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

Review 9.  The dichotomy of p53 regulation by noncoding RNAs.

Authors:  Qipan Deng; Lindsey Becker; Xiaodong Ma; Xiaoming Zhong; Ken Young; Kenneth Ramos; Yong Li
Journal:  J Mol Cell Biol       Date:  2014-04-04       Impact factor: 6.216

Review 10.  Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy.

Authors:  Jian-Jun Zhao; Ruben D Carrasco
Journal:  Cancer Res       Date:  2014-09-16       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.